Resmed (RMD) Capital Expenditures Growth (1y) (2010 - 2026)
Resmed (RMD) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.12 Bn | 120.90 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.44 Bn | 27.78 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.12 Bn | 22.68 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 21.73% |
| 10 | Baxter International | 11.93 Bn | 9.91 Bn | 891.00 Mn | 12.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.83% |
| Dec 31, 2025 | 38.24% |
| Sep 30, 2025 | 140.84% |
| Jun 30, 2025 | 22.93% |
| Mar 31, 2025 | -1.86% |
| Dec 31, 2024 | -11.60% |
| Sep 30, 2024 | -40.60% |
| Jun 30, 2024 | -27.77% |
| Mar 31, 2024 | -26.46% |
| Dec 31, 2023 | -14.61% |
| Sep 30, 2023 | 3.37% |
| Jun 30, 2023 | 20.27% |
| Mar 31, 2023 | -40.52% |
| Dec 31, 2022 | -10.05% |
| Sep 30, 2022 | 6.28% |
| Jun 30, 2022 | 2.64% |
| Mar 31, 2022 | 83.77% |
| Dec 31, 2021 | -12.98% |
| Sep 30, 2021 | 102.50% |
| Jun 30, 2021 | 55.30% |